Search - tctmd.com

Displaying 341 - 360 of 671

Sort: Relevancy | Date

Presentation TCT 2014

Are GP IIb/IIIa Inhibitors Still Useful?

Presenter: Marco Valgimigli

September 13, 2014

Presentation

Aspirin Treatment and Outcomes After PCI

Presenter: Katharina Mayer

August 25, 2014

Presentation

Bivalirudin vs Heparin in Patients Planned for PCI

Presenter: Matthew A. Cavender

August 20, 2014

Presentation

Early High-Dose Rosuvastatin and Cardioprotection

Presenter: M. Leoncini

August 19, 2014

Presentation

Contemporary Patterns of Discharge Aspirin Dosing After Acute MI in the United States

Presenter: H.M. Hall

August 13, 2014

Presentation

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

Presenter: Akshay Bagai

August 12, 2014

Presentation

Issues with DAPT: An Expert Case-Based Discussion

Presenter: Jonathan Halperin, Ajay Kirtane, Roxana Mehran

July 29, 2014

Presentation

Pharmacotherapy for Primary PCI - Late Breaking Trials: EUROMAX, HEAT-PPCI, BRIGHT, and BRAVE 4

Presenter: Gregg W. Stone

July 23, 2014

Presentation

Variability of Individual Platelet Reactivity Over Time in Patients Treated with Clopidogrel

Presenter: W. Hochholzer

July 21, 2014

Presentation

STREAM Substudy: Outcomes of Pharmacoinvasive Strategy for Successful vs Failed Fibrinolysis and Primary PCI in AMI

Presenter: R.C. Welsh

July 16, 2014

$Unfractionated Heparin vs Bivalirudin in Primary PCI: An Open-label, Single-Center, Randomized Trial$

Presentation

Unfractionated Heparin vs Bivalirudin in Primary PCI: An Open-label, Single-Center, Randomized Trial

Presenter: A. Shahzad

July 10, 2014

Presentation

DAPT in Stable CAD in Modern Practice: Prevalence, Correlates, and Impact on Prognosis

Presenter: Gilles Lemesle

July 02, 2014

Presentation

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Presenter: J.A. Udell

June 17, 2014

Presentation

Clopidogrel Prescription Filling Delays and Cardiovascular Outcomes in a Pharmacy System Integrating Inpatient and Outpatient Care

Presenter: J.B. Byrd

June 16, 2014

Presentation

Efficacy, Safety of Rivaroxaban vs Warfarin in Elderly Patients with Nonvalvular A-fib

Presenter: Jonathan L. Halperin

June 09, 2014

Presentation

Delay in Filling First Clopidogrel Prescription after Coronary Stenting Is Associated with an Increased Risk of Death and MI

Presenter: Nicholas L. Cruden

May 28, 2014

$Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial$

Presentation EuroPCR 2014

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Presenter: Uwe Zeymer

May 21, 2014

Presentation

Meta-analysis of RCTs Comparing Short-term vs Long-term DAPT following DES

Presenter: G. El-Hayek

May 19, 2014

Presentation

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Presenter: Stefanie Schulz

May 14, 2014

Presentation

Anticoagulant and Antiplatelet Therapy in A-fib Patients Undergoing PCI

Presenter: K. Goto

April 30, 2014

Advertisement

Are GP IIb/IIIa Inhibitors Still Useful?

Aspirin Treatment and Outcomes After PCI

Bivalirudin vs Heparin in Patients Planned for PCI

Early High-Dose Rosuvastatin and Cardioprotection

Contemporary Patterns of Discharge Aspirin Dosing After Acute MI in the United States

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

Issues with DAPT: An Expert Case-Based Discussion

Pharmacotherapy for Primary PCI - Late Breaking Trials: EUROMAX, HEAT-PPCI, BRIGHT, and BRAVE 4

Variability of Individual Platelet Reactivity Over Time in Patients Treated with Clopidogrel

STREAM Substudy: Outcomes of Pharmacoinvasive Strategy for Successful vs Failed Fibrinolysis and Primary PCI in AMI

Unfractionated Heparin vs Bivalirudin in Primary PCI: An Open-label, Single-Center, Randomized Trial

DAPT in Stable CAD in Modern Practice: Prevalence, Correlates, and Impact on Prognosis

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Clopidogrel Prescription Filling Delays and Cardiovascular Outcomes in a Pharmacy System Integrating Inpatient and Outpatient Care

Efficacy, Safety of Rivaroxaban vs Warfarin in Elderly Patients with Nonvalvular A-fib

Delay in Filling First Clopidogrel Prescription after Coronary Stenting Is Associated with an Increased Risk of Death and MI

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Meta-analysis of RCTs Comparing Short-term vs Long-term DAPT following DES

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Anticoagulant and Antiplatelet Therapy in A-fib Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content